These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Author: Piazza M, Orlando R, Tosone G, Tiseo D, Conte MC, Minervini F, Santoro G, Scordino F, Vitale D.
    Journal: Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479.
    Abstract:
    In a study of 87 patients with chronic hepatitis C, 12 months' treatment with interferon alfa-2b at a dose of 6 million units (MU) three times per week seemed to be more effective than treatment with 3 MU three times a week for two months plus 1.5 MU three times a week for 10 months in increasing the percentage of long term responders. The percentage of patients in whom alanine amino-transferase activities returned to normal was highest in the 6 MU group, as was the percentage of responders who sustained this normal activity after treatment. Side effects were moderate and self-limited in most patients.
    [Abstract] [Full Text] [Related] [New Search]